Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients.

MLA

Hori, Hikaru, et al. “Effects of Olanzapine on Plasma Levels of Catecholamine Metabolites, Cytokines, and Brain-Derived Neurotrophic Factor in Schizophrenic Patients.” International Clinical Psychopharmacology, vol. 22, no. 1, Jan. 2007, pp. 21–27. EBSCOhost, https://doi.org/10.1097/YIC.0b013e3280103593.

APA

Hori, H., Yoshimura, R., Yamada, Y., Ikenouchi, A., Mitoma, M., Ida, Y., & Nakamura, J. (2007). Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients. International Clinical Psychopharmacology, 22(1), 21–27. https://doi.org/10.1097/YIC.0b013e3280103593

Chicago

Hori, Hikaru, Reiji Yoshimura, Yasuhisa Yamada, Atsuko Ikenouchi, Masae Mitoma, Yoshishige Ida, and Jun Nakamura. 2007. “Effects of Olanzapine on Plasma Levels of Catecholamine Metabolites, Cytokines, and Brain-Derived Neurotrophic Factor in Schizophrenic Patients.” International Clinical Psychopharmacology 22 (1): 21–27. doi:10.1097/YIC.0b013e3280103593.